当前位置: X-MOL 学术Drug. Discov. Today › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors
Drug Discovery Today ( IF 7.4 ) Pub Date : 2018-11-29 , DOI: 10.1016/j.drudis.2018.11.012
Lanlan Jing , Gaochan Wu , Dongwei Kang , Zhongxia Zhou , Yuning Song , Xinyong Liu , Peng Zhan

Butyrylcholinesterase (BChE) is considered a promising drug target for the treatment of moderate to severe Alzheimer’s disease (AD). Here, we review medicinal-chemistry strategies that are currently available for the discovery of selective BChE inhibitors.



中文翻译:

发现选择性丁酰胆碱酯酶抑制剂的当代药物化学策略

丁酰胆碱酯酶(BChE)被认为是治疗中度至重度阿尔茨海默氏病(AD)的有前途的药物靶标。在这里,我们审查了目前可用于发现选择性BChE抑制剂的药物化学策略。

更新日期:2018-11-29
down
wechat
bug